PMR report: Reimbursement is crucial for biological medicines
Introduction of biosimilar drugs to reimbursement in Poland takes almost the longest time in Europe. Nevertheless, obtaining reimbursement is a…
biological drugs
Biosimilar medicines: Sandoz will comercialise Polpharma’s SM drug
Polpharma Biologics and global generic giant Sandoz will jointly launch a biosimilar to the multiple sclerosis (SM) biological drug. This…
Bioceltix will develop a biological drug for horses
Bioceltix, a Wroclaw-based start-up, is starting a project to develop a biological drug for veterinary medicine. Based on stem cells,…
Artur Chabowski will no longer be president of Mabion
Artur Chabowski resigned from the position of President of Mabion, a Polish biotechnology company. It will come into force on…
